Opportunities and challenges for pharma-healthtech partnerships

Partnerships between pharma and healthtech have great potential—but delivering on those partnerships requires overcoming challenges. Expectation and communications can sometimes make effective collaboration difficult. Listen as Ameya Phadke, patient non-pharma solutions leader at Chiesi Group, Dennis Hermann, Head of Europe at Kaia Health and Dan Weinstein, associate principal digital medicine practice lead at ZS, discuss how these partnerships can work successfully and what broader trends they see relating to these partnerships.

You’ll learn more about:

  • Key considerations for entering, maintaining and managing partnerships from both pharma and healthtech companies’ points of view
  • What works well—and what doesn’t—in these partnerships, and how to collaborate successfully
  • The future of pharma-healthtech collaborations


About Author

You may also like


Senior-focused VR company MyndVR will be covered by New York insurer

VR digital therapeutic company MyndVR announced AgeWell New York’s insurance plans for Medicare and Medicaid patients would cover its senior-focused

GoodRx shared health data with Google and Facebook, FTC says

The Federal Trade Commission on Wednesday alleged drug-cost and telehealth platform GoodRx shared consumers’ personal health information with third parties